Dr. Tomislav Dragovich, MD, PhD

Dr. Dragovich practices at Baptist MD Anderson Cancer Physicians in Jacksonville, Florida.

Dr. Dragovich's NPI, 1518979715, was assigned on August 13, 2006. Dr. Dragovich graduated from University of Belgrade Faculty of Medicine in 1988. Dr. Dragovich holds Florida license ME166799.

Dr. Dragovich's primary practice is Baptist MD Anderson Cancer Physicians, at 1301 Palm Ave, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-7300.

Dr. Dragovich's primary practice is Baptist MD Anderson Cancer Physicians in Jacksonville, Florida. Dr. Dragovich is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Dr. Dragovich to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dragovich practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Dragovich's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Dragovich is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Dragovich's licenses on file in 3 states: Florida, Arizona and Illinois.

Dmand AI lists colorectal cancer and prostate cancer among the conditions Dr. Dragovich treats.

CMS data shows 145 Medicare services from Dr. Dragovich across 4 procedure codes in 2024, all of them office visits, for 43 Medicare patients. Medicare paid $14,688 for them. Every service was in an office.

CMS counts 43 Medicare patients who saw Dr. Dragovich in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dragovich's median patient age at 70, with 48% women.

In 2024, Dr. Dragovich wrote 229 Medicare Part D claims for 46 patients. 87% of them were for generic drugs. CMS names the drug for 132 of them, across 6 drugs with 11 or more claims each, at $67,383 in total drug cost. In 2023, CMS named 157 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Dragovich for performance year 2024, reported as part of a group. Dr. Dragovich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dragovich as offering telehealth.

Dmand AI links 43 papers to Dr. Dragovich, published from 2006 to 2025. 2014 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Pancreatic Neoplasms and Deoxycytidine. Dr. Dragovich has published most often in Cancer Chemother Pharmacol. Dr. Dragovich's most frequent co-authors are John C. Chang, MD, Heinz-Josef Lenz, MD and Vivek Subbiah, MD.

Dmand AI links Dr. Dragovich to 6 clinical trials, 4 of them phase 2 studies. Conditions studied include Pancreatic Neoplasms, Adenocarcinoma Of Esophagus and Carcinoma, Pancreatic Ductal. Pancreatic Cancer Research Team sponsors the most, 3.

CMS Open Payments shows 49 general payments to Dr. Dragovich from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Eli Lilly and Company paid the most, $7,831.

Dr. Dragovich graduated from University of Belgrade Faculty of Medicine in 1988. Dr. Dragovich is a member of ASCO.

Dr. Dragovich is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.